MedTrace Logo

Luteal Support in Frozen-Thawed Embryo Transfer Cycles

NCT03948022 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2022-01-11

No results posted yet for this study

Summary

This study evaluates the clinical efficacy of 3 different luteal phase support in patients undergoing frozen-thawed embryo transfer cycles. Endometrium preparation will be hormone replacement in all cycles. Starting from day 11, group 1 will receive 100 mg micronized progesterone parenteral daily injections, group 2 will receive 90 mg bioadhesive gel vaginal twice daily and group 3 will receive 40 mg oral dydrogesterone daily tablets.

Conditions

  • Implantation; Placenta
  • Pregnancy Loss
  • Frozen Embryo
  • Luteal Support
  • Luteal Phase Defect
  • Assisted Reproduction

Interventions

DRUG

Dydrogesterone 10Mg Tablet (duphaston)

40 mg daily oral tablets

DRUG

Progesterone 50Mg/mL Oil

100 mg daily intramuscular injections

DRUG

Crinone 8% Vaginal Gel

180 mg daily vaginal gels

Sponsors & Collaborators

  • Centrum Clinic IVF Center

    lead OTHER

Principal Investigators

  • Emre Pabuccu, Assoc. Prof. · Ufuk University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2021-12-18
Completion
2021-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03948022 on ClinicalTrials.gov